Duration of Antimicrobial Therapy in Community Acquired Pneumonia: Less Is More
Community acquired pneumonia (CAP) represents the most common cause of infection-related morbidity and mortality worldwide. Appropriate treatment of CAP is challenging and sometimes limited by the availability to obtain rapid and timely identification of the etiologic agent in order to initiate or d...
Saved in:
| Main Authors: | Marilia Rita Pinzone, Bruno Cacopardo, Lilian Abbo, Giuseppe Nunnari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2014/759138 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgical Site Infection by Corynebacterium macginleyi in a Patient with Neurofibromatosis Type 1
by: Bruno Cacopardo, et al.
Published: (2013-01-01) -
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis
by: Benedetto Maurizio Celesia, et al.
Published: (2014-01-01) -
Isolated Laryngeal Leishmaniasis in Immunocompetent Patients: An Underdiagnosed Disease
by: Salvatore Cocuzza, et al.
Published: (2013-01-01) -
Guidelines for antimicrobial treatment of community acquired pneumonia in adults
by: TJ Marrie
Published: (1993-01-01) -
Effectiveness of antimicrobial therapy for community-acquired pneumonia in real clinical practice
by: O. M. Uryasev, et al.
Published: (2022-01-01)